American Journal of Epidemiology Vol. 153, No. 2 : 145-152
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women
1 Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
2 Present address: Assisted Reproductive Technology Epidemiology Unit, Women's Health and Fertility Branch, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA.
In observational studies, estrogen replacement therapy is associated with decreased cardiovascular disease rates and increased breast cancer rates. Recent evidence suggests that the impact of estrogen use on disease outcomes may vary by body mass. In a prospective study of 290,827 postmenopausal US women with no history of cancer or cardiovascular disease at enrollment in 1982, the authors examined the association between postmenopausal estrogen use and all-cause, coronary heart disease, stroke, all-cancer, and breast cancer death rates and whether these associations differed by body mass. After 12 years of follow-up, results from Cox proportional hazards models showed that all-cause death rates were lower among baseline estrogen users than never users (rate ratio (RR) = 0.82, 95% confidence interval (CI): 0.78, 0.87). The lowest relative risk was found for coronary heart disease (RR = 0.66, 95% CI: 0.58, 0.77). The inverse association between estrogen use and coronary heart disease mortality was strongest for thin women (body mass index <22 kg/m2) (RR = 0.49, p for interaction = 0.02). Breast cancer mortality did not increase with estrogen use overall, and no increased risk was observed for thin or heavy women. In this population, the reduction in coronary heart disease mortality among estrogen users was greatest for thinner women. Additional studies are needed to confirm or refute these results.
body mass index; cardiovascular diseases; estrogen replacement therapy; mortality
Abbreviations: BMI, body mass index; CI, confidence interval; ICD-9, International Classification of Diseases, Ninth Revision; RR, rate ratio
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.-N. Vercambre, A. Fournier, M.-C. Boutron-Ruault, F. Clavel-Chapelon, V. Ringa, and C. Berr Differential Dietary Nutrient Intake according to Hormone Replacement Therapy Use: An Underestimated Confounding Factor in Epidemiologic Studies? Am. J. Epidemiol., December 15, 2007; 166(12): 1451 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tice, A. Kanaya, T. Hue, S. Rubin, D. S. M. Buist, A. LaCroix, J. V. Lacey Jr, J. A. Cauley, S. Litwack, L. A. Brinton, et al. Risk Factors for Mortality in Middle-aged Women Arch Intern Med, December 11, 2006; 166(22): 2469 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pentti, R. Honkanen, M. T Tuppurainen, L. Sandini, H. Kroger, and S. Saarikoski Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study Eur. J. Endocrinol., January 1, 2006; 154(1): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Coronary Heart Disease Obstet. Gynecol., October 1, 2004; 104(4_suppl): 41S - 48S. [Full Text] [PDF]
|
|
|
|
|
|
Stroke Obstet. Gynecol., October 1, 2004; 104(4_suppl): 97S - 105S. [Full Text] [PDF]
|
|
|
|
 |
|
 ESHRE Capri Workshop Group Hormones and breast cancer Hum. Reprod. Update, July 1, 2004; 10(4): 281 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Grodstein, T. B. Clarkson, and J. E. Manson Understanding the Divergent Data on Postmenopausal Hormone Therapy N. Engl. J. Med., February 13, 2003; 348(7): 645 - 650. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Decensi, U. Omodei, C. Robertson, B. Bonanni, A. Guerrieri-Gonzaga, F. Ramazzotto, H. Johansson, S. Mora, M. T. Sandri, M. Cazzaniga, et al. Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women Circulation, September 3, 2002; 106(10): 1224 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan Postmenopausal Hormone Replacement Therapy: Scientific Review JAMA, August 21, 2002; 288(7): 872 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rodriguez, E. E. Calle, M. A. Hlatky, and D. Boothroyd Postmenopausal Hormone Replacement, Body Mass Index, and Quality of Life JAMA, May 1, 2002; 287(17): 2210 - 2211. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsuda, Y. Kinoshita, K. Kimura, I. Nishio, and Y. Masuyama Electron Paramagnetic Resonance Investigation on Modulatory Effect of 17{beta}-Estradiol on Membrane Fluidity of Erythrocytes in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1306 - 1312. [Abstract] [Full Text] [PDF]
|
|